TY  - PAT 
AU  - Carretero Coca, Rafael
PY  - 2023
UR  - https://hdl.handle.net/10481/107818
AB  - The present invention provides antibodies, that bind to human CEACAM6 and are able to relieve CEACAM6-mediated immunosuppression, wherein said antibodies have reduced side-effects during treatment. The present invention further provides isolated...
LA  - eng
PB  - WIPO/PCT
KW  - CEACAM6
KW  - Antibody
KW  - Cancer
TI  - Anti-cecam6 antibodies with reduced side-effects
ER  -